Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Perhaps the most powerful aspect of CGM readings are using them in combination with an insulin pump to automate insulin delivery. Insulin pumps dose insulin throughout the day to help people ...

As part of National Diabetes Awareness Month, the Children's Diabetes Foundation is encouraging Type 1 diabetics to post on ...

Tandem Diabetes Care and Insulet executives this week touted the strong demand they’ve seen for their insulin pumps among people with Type 2 diabetes, tipping that adoption could be even greater ...

When Wright's mealtime insulin was down to a partial vial in January, she ate fewer carbohydrates to ration the amount of medication she dispensed via a pump. The insulin pump calibrates the ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday.

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Medtronic has issued a voluntary recall on some of its insulin pumps over concerns about the length of their battery life. The Dublin-based medical-device maker said Friday that customers of its ...

Nov 7(Reuters) - Insulet (PODD.O), opens new tab raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps. Shares of the medical device maker ...

Can type 1 diabetes be managed or cured? Yes! Breakthrough treatments like Donislecel and Teplizumab offer hope for better ...